Wednesday, October 7, 2026

A Qualitative Primer on the Nicotine Pouch Space

Nicotine pouches show low brand loyalty and sharply varied preferences, with U.S. users favoring Velo Plus over Velo Max and expecting it to overtake Zyn by 2027.

BTI $120B

Sylence Capital Oct 7 4 clicks

Oct 7 UBER $140B

ezCater and the Other Half of Uber's FCF

MBI Deep Dives 1 click

Oct 7 LHX $44B

L3Harris Technologies (NYSE: LHX) Upgraded Rating: Accumulate

Cestrian Capital Research 1 click

From X

@ACapitalLP Oct 7 1 click

A Capital on X

Is the $NN trade completely over? https://t.co/wwSNNhdxl7

@stockgutter Oct 7 1 click

SG on X

don't listen to the clowns saying this should be ignored because its part of a long-standing diversification plan. If they bothered to read the Form 144 they would know that he put in a brand new sales plan in June 2026. Why? Q2 was when $DUOL posted declining y-o-y earnings.

@convequity Oct 7

Convequity on X

$NTSK began as a CASB vendor, governing how employees use SaaS applications at the point of use. Years of that work gave it application-specific knowledge of user behavior, data movement, and risk inside cloud apps. That knowledge carries over to AI. Netskope inspects prompts, responses, and file transfers inline and in real time, and it can respond with something more precise than a block: preventing a risky copy-and-paste, stepping up authentication for a sensitive interaction, or coaching the user as they work. The part that matters more comes after the prompt. AI adds autonomy and chaining, so a single human interaction can trigger many machine-executed actions across tools, data stores, and services, often outside one user session. If data is over-permissioned and tools are loosely scoped, an agent can stay inside its allowed permissions and still cause harm faster than a person can intervene. The context Netskope gathers at the interaction can be carried forward to constrain that downstream execution: who the user is, what data is involved, which action was taken, and how risky it looks. So Netskope's edge is that it already knows the user, the data and the action at the moment of the prompt, and it can use that context to limit what an agent does next. It is now building the agent side directly. Its Agentic Broker rates agent actions by risk before they run, and its AI posture management for agents built on AWS, Azure and GCP is still in preview. That is the part to watch.

@KEDM_COM Oct 7

KEDM.com on X

Both Up Fintech $TIGR and Futu $FUTU benefited from Asians YOLO-ing into 3x levered long MU and SPCX ETFs, with FUTU now up significantly since the regulatory crackdown in May. They only started throttling Mainland accounts in mid-June so the real impact won't be visible until next quarter. ~12x P/E ex-Mainland if you annualize Q2, although Q3 is bound to be a little weaker.

@stockgutter Oct 7

SG on X

Form 144 indicates that $DUOL CEO is dumping $16.3m worth of stock. that's a shit-ton in any language https://t.co/57BBYQsRo2

@partners_road Oct 7 1 click

RiverRoadPartners on X

Another lousy quarter at $LEVI. And what are they blaming on the call? Weather. The lamest excuse you can use in retail.

@orrdavid Oct 7

David Orr on X

$LULU just now https://t.co/CMBjD201I0

@P_Remarks Oct 7 1 click

Prepared Remarks on X

$24b in equity from the gulf funds cut Larry’s personal guarantee by 50%. Liontree, Redbird, and the non Larry Ellison family money cuts it further Another $orcl boogeyman story that’s a nothingburger https://t.co/QifC1wSxtE

Cerebras: OpenAI's Nvidia Move Doesn't Break The 750 MW Deal

Cerebras retains its 750 MW commitment despite OpenAI's Nvidia move, but TSMC supply, owned capacity and gross-margin recovery remain the…

CBRS $39B

Deep Value Investing Oct 7

💥New Chapter 11 Bankruptcy Filing - And Go Concepts, LLC (Salad and Go)💥

Salad and Go filed Chapter 11 after its Texas and Oklahoma expansion failed, seeking to sell 65 leases to Dutch Bros for $105 million as 7…

BROS $5.5B

PETITION Oct 7 3 clicks

West Pharma: Still A Buy, But Expectations Are Rising

West Pharmaceutical Services’ GLP-1 demand, HVP upgrades and Annex 1 conversions support double-digit growth, but its premium valuation…

WST $26B

Petri Dish Reports Oct 7

Research Roundup Vol. LV

OpenAI’s enterprise privacy push and Synopsys’s Factory 2 royalty model anchor a technology roundup, alongside oil above $100 and Bitcoin’s…

SNPS $97B

Monte Independent Investment Research Oct 7

Adobe (NASDAQ: ADBE) Stock Rating: Accumulate After Q3 FY11/26 Earnings

Adobe rates Accumulate at $189-$266 after Q3 FY26 revenue grew 12.9%, while management guided slower growth and RPO growth decelerated.

ADBE $93B

Cestrian Capital Research Oct 7 2 clicks

BP p.l.c.: An Oil And Gas Play Primed For Outperformance

BP is investing $10 billion annually in oil and gas through 2027 as higher crude prices, LNG expansion and debt reduction support earnings,…

BP $123B

The Asian Investor Oct 7 6 clicks

Marvell 2026 Investor Day: Irrational Recap

Marvell’s 2026 investor day draws a skeptical review of its optical connectivity, DSP and AI infrastructure claims, while crediting its…

MRVL $241B

Irrational Analysis Oct 7 2 clicks

New Position (ONON): Game is On

On Holding (ONON) is gaining sportswear share, expanding store space and launching soccer with Kylian Mbappé as investors debate U.S.

ONON $11B

Aurelion Research Oct 6 3 clicks

Rollins (ROL), Verisure (VSURE), and the cost of standing still (Part 1)

Rollins’ recurring pest-control base requires ongoing spending to replace departing customers, a concern tied to its nearly 50%…

ROL $16B

Best Anchor Stocks Oct 6

Deep Dive: Intuit ($INTU)

Intuit’s $21.4 billion software franchise faces AI-driven pricing pressure in tax and accounting, even as QuickBooks and TurboTax retain…

INTU $79B

Rebound Capital Oct 6 4 clicks

ENS · short

Enersys

EnerSys faces a short thesis as data-center and warehouse vehicle customers shift from lead-acid batteries to lithium-ion.

ENS $6.4B

Value Investors Club Jun 5

$ELAL: El Al is a wartime monopoly at 2x EBITDA. Is that a trap? | ASB Partners

El Al trades near 2x EBITDA after wartime near-monopoly profits, with $1.3 billion of net cash and owned aircraft weighed against…

ELALF $3.5B

Yet Another Value Podcast Aug 20 13 clicks

BAC 2026-08-20

Bank of America Preferreds: Better Propositions Available Than Series GG

Bank of America’s BAC.PR.B yields just over 6% near par, while discounted lower-coupon series such as BAC.PR.P offer better value despite…

BAC $375B

Prakhar Agarwal, CFA Aug 20 1 click

Moderna: An Atypical Investment with an Asymmetric Payoff

Moderna's Phase 3 intismeran autogene trial met its recurrence-free survival endpoint in adjuvant melanoma, supporting an asymmetric…

MRNA $79B

Bireme Capital - Investor Letters Aug 20 1 click

(Guest) ConocoPhillips - Uplift From Hidden CITGO Refining Value

ConocoPhillips’ CITGO claims cover $1.5 billion under Amber’s deal, with a proposed Venezuela settlement targeting roughly $4 billion more.

COP $160B

HFI Research Aug 20

Instacart’s Unit Economics, and Implications for DoorDash

Instacart’s per-order unit economics provide a benchmark for assessing DoorDash’s LTM profitability and operating model.

DASH $84B

MBI Deep Dives Aug 20 5 clicks

The Neoclouds Series, Part 2: CoreWeave

CoreWeave built the most leveraged neocloud model, stockpiling Nvidia GPUs and renting AI compute from rapidly expanded data centers.

CRWV $46B

Kakashii's Materials Aug 20 1 click

What Top Funds are Buying & Selling

June 2026 13F filings show Baupost doubling Genuine Parts ahead of its 2027 split and Ratan Capital making Silicon Motion its largest…

GPC $18BSIMO $8.9B

Rebound Capital Aug 20

CCC Is in the Middle of the Wreckage

CCC, the dominant auto physical-damage claims estimator, connects 27 of the top 30 insurers with 31,000 repair shops as takeout rumors…

CCC $4.5B

scuttleblurb Aug 20 17 clicks

TEM 2026-08-20

Tempus AI Just Had Their Entire Strategy Validated By Moderna's Vaccine Advance

Tempus AI's diagnostics and data businesses grew Q2 2026 revenue 19.4% year over year, with FDA approvals, expanded tests and pricing aimed…

TEM $12BMRNA $79B

Robert J. Lake Aug 20 2 clicks

Wednesday, October 7, 2026

A Capital on X

SG on X

Convequity on X

KEDM.com on X

SG on X

RiverRoadPartners on X

David Orr on X

Prepared Remarks on X

Investor Letters

Publications we follow

Newsletters 92

YouTube 4

Blogs 12

Seeking Alpha 46 of 219

X accounts we follow

Investor letters we follow

Sectors